Reducing histone acetylation rescues cognitive deficits in a mouse model of Fragile X syndrome.

Reducing histone acetylation rescues cognitive deficits in a mouse model of Fragile X syndrome.
复制标题

DOI:
10.1038/s41467-018-04869-3
复制
发表时间:
2018-06-27
影响因子:
16.6
通讯作者:
Zhao X
Zhao X
中科院分区:
综合性期刊1区
文献类型:
--
作者:
Li Y;Stockton ME;Eisinger BE;Zhao Y;Miller JL;Bhuiyan I;Gao Y;Wu Z;Peng J;Zhao X

文献摘要

参考文献

被引文献

相似文献

脆性X综合征(FXS)是最常见的遗传性智力残疾,由脆性X智力低下蛋白(FMRP)的缺失引起。患有FXS的患者患有终身认知障碍,但FMRP在成人大脑中的功能以及FXS中与年龄相关的认知下降的潜在机制尚未完全了解。在这里,我们报告说,FMRP的损失导致增加组蛋白乙酰转移酶EP300和泛素化介导的降解组蛋白去乙酰化酶HDAC1在成年海马神经干细胞(NSC)的蛋白质合成。因此,FMRP缺陷型NSC表现出组蛋白乙酰化升高和年龄相关的NSC耗竭,导致成熟成年小鼠的认知障碍。减少组蛋白乙酰化拯救成熟成年FMRP缺陷小鼠的神经发生和认知缺陷。我们的工作揭示了FMRP和组蛋白乙酰化在认知中的作用,并为治疗成人FXS患者提供了一种潜在的新治疗策略。脆性X智力低下蛋白(FMRP)的缺失导致脆性X综合征,与认知功能障碍有关。在这里,作者表明,缺乏FMRP的小鼠表现出海马神经发生减少和认知缺陷,这可以通过减少组蛋白乙酰化来挽救。
Fragile X syndrome (FXS) is the most prevalent inherited intellectual disability, resulting from a loss of fragile X mental retardation protein (FMRP). Patients with FXS suffer lifelong cognitive disabilities, but the function of FMRP in the adult brain and the mechanism underlying age-related cognitive decline in FXS is not fully understood. Here, we report that a loss of FMRP results in increased protein synthesis of histone acetyltransferase EP300 and ubiquitination-mediated degradation of histone deacetylase HDAC1 in adult hippocampal neural stem cells (NSCs). Consequently, FMRP-deficient NSCs exhibit elevated histone acetylation and age-related NSC depletion, leading to cognitive impairment in mature adult mice. Reducing histone acetylation rescues both neurogenesis and cognitive deficits in mature adult FMRP-deficient mice. Our work reveals a role for FMRP and histone acetylation in cognition and presents a potential novel therapeutic strategy for treating adult FXS patients. Loss of fragile X mental retardation protein (FMRP) leads to fragile X syndrome, associated with cognitive dysfunction. Here the authors show that mice lacking FMRP show reduced hippocampal neurogenesis and cognitive deficits, which can be rescued by reducing histone acetylation.
DOI: 10.1016/j.neuropharm.2015.07.017
发表时间: 2016-01
期刊: Neuropharmacology
影响因子: 4.7
作者:
Bowling H;Bhattacharya A;Zhang G;Lebowitz JZ;Alam D;Smith PT;Kirshenbaum K;Neubert TA;Vogel C;Chao MV;Klann E
通讯作者: Klann E
DOI: 10.1016/j.cell.2011.05.024
发表时间: 2011-06-24
期刊: Cell
影响因子: 64.5
作者:
Bonaguidi MA;Wheeler MA;Shapiro JS;Stadel RP;Sun GJ;Ming GL;Song H
通讯作者: Song H
DOI: 10.1016/j.beproc.2011.12.004
发表时间: 2012-03-01
影响因子: 1.3
作者:
Heyser, Charles J.;Chemero, Anthony
通讯作者: Chemero, Anthony
DOI: 10.1126/scitranslmed.aab4109
发表时间: 2016-01-13
影响因子: 17.1
作者:
Berry-Kravis, Elizabeth;Portes, Vincent Des;von Raison, Florian
通讯作者: von Raison, Florian
DOI: 10.1097/yco.0000000000000131
发表时间: 2015-03
影响因子: 6.9
作者:
Hagerman RJ;Polussa J
通讯作者: Polussa J